Systematic review and meta-analysis including 27 studies in Barrett's oesophagus: aberrant p53 was linked to higher progression to HGD/EAC (8 vs 0.3 per 100 person-years; cohort RR 10.2), but sensitivity was 42% in non-dysplastic disease, judged suboptimal.
Meta-analysisn = 27 studies
Sawas et al. Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-Analysis